News
AAPG
15.35
+3.09%
0.46
Weekly Report: what happened at AAPG last week (0921-0925)?
Weekly Report · 1d ago
Weekly Report: what happened at AAPG last week (0914-0918)?
Weekly Report · 09/21 09:12
Ascentage Pharma Group International reports 1H results
Seeking Alpha · 09/17 19:45
Weekly Report: what happened at AAPG last week (0907-0911)?
Weekly Report · 09/14 09:12
Weekly Report: what happened at AAPG last week (0831-0904)?
Weekly Report · 09/07 09:11
Analysts Offer Insights on NA Companies: PACS Group Inc (PACS) and Ascentage Pharma Group International Unsponsored ADR (AAPG)
TipRanks · 09/02 13:10
Weekly Report: what happened at AAPG last week (0824-0828)?
Weekly Report · 08/31 09:12
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 08/27 12:05
CICC Sticks to Its Buy Rating for Ascentage Pharma Group International (6855)
TipRanks · 08/27 05:18
Weekly Report: what happened at AAPG last week (0817-0821)?
Weekly Report · 08/24 09:13
Ascentage Pharma Earnings Call Highlights Pipeline Momentum
TipRanks · 08/24 00:19
Jeet Mukherjee Initiates Buy on Ascentage Pharma, Citing 2027 NRDL Lisaftoclax Catalyst, Late‑Stage Pipeline Readouts, and Cash Runway Through 2027
TipRanks · 08/21 14:05
Analysts Offer Insights on NA Companies: Ascentage Pharma Group International Unsponsored ADR (AAPG), Fatpipe, Inc. (FATN) and Aptera Motors Corp. Class B (SEV)
TipRanks · 08/21 13:30
Oppenheimer Keeps Their Buy Rating on Ascentage Pharma Group International Unsponsored ADR (AAPG)
TipRanks · 08/21 11:55
BTIG Reiterates Buy on Ascentage Pharma Group, Maintains $48 Price Target
Benzinga · 08/21 09:47
Transcript: Ascentage Pharma Group H1 2026 Earnings Conference Call
Benzinga · 08/21 06:07
Reported Earlier, Ascentage Pharma Group H1 EPS $(0.32) Beats $(0.44) Estimate, Sales $44.541M Beat $24.070M Estimate
Benzinga · 08/20 06:18
Ascentage Pharma Group International GAAP EPS of -$0.32 beats by $0.23, revenue of $44.5M misses by $7.73M
Seeking Alpha · 08/20 05:38
Quant snapshot: Keysight Technologies and Hovnanian Enterprises lead top-rated names as Chagee Holdings Limited and Webull Corporation Payments lag
Seeking Alpha · 08/17 12:56
Weekly Report: what happened at AAPG last week (0810-0814)?
Weekly Report · 08/17 09:13
More
Webull provides a variety of real-time AAPG stock news. You can receive the latest news about Ascentage Pharma Group International through multiple platforms. This information may help you make smarter investment decisions.
About AAPG
Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.